Cucurbitacin-I (Elatericin B, JSI 124, NSC 521777), a natural cell-permeable triterpenoid isolated from Cucurbitaceae, is a novel selective inhibitor of JAK2/STAT3.
- Inhibitors
- Antibodies
- Compound Libraries
- New Products
- Contact Us
research use only
Cat.No.S8152
| Related Targets | EGFR STAT Pim |
|---|---|
| Other JAK Inhibitors | AZD1480 WP1066 Momelotinib (CYT387) Filgotinib (GLPG0634) AT9283 Gandotinib (LY2784544) TG101209 Cerdulatinib (PRT062070) hydrochloride Pacritinib NVP-BSK805 2HCl |
|
In vitro |
DMSO
: 100 mg/mL
(194.3 mM)
Ethanol : 100 mg/mL Water : Insoluble |
|
In vivo |
|||||
Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)
Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)
Calculation results:
Working concentration: mg/ml;
Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )
Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.
Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.
Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.
| Molecular Weight | 514.65 | Formula | C30H42O7 |
Storage (From the date of receipt) | 3 years -20°C powder |
|---|---|---|---|---|---|
| CAS No. | 2222-07-3 | -- | Storage of Stock Solutions |
|
|
| Targets/IC50/Ki |
JAK2
STAT3
|
|---|---|
| In vitro |
Cucurbitacin-I (Elatericin B, JSI 124, NSC 521777) can efficiently inhibit the proliferation of GBM cells by blocking phosphorylation of STAT3, which in turn lead to the downregulation of antiapoptotic gene products and promote apoptosis. In addition, this compound induced G2/M phase arrest in GBM via downregulation of cyclin B1 and cdc2 expression. |
References |
|
Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.